Laboratório de Percepção, Neurociências e Comportamento (LPNeC), Universidade Federal da Paraíba (UFPB), João Pessoa, PB, Brazil.
Braz J Psychiatry. 2020 Jan-Feb;42(1):27-32. doi: 10.1590/1516-4446-2018-0331.
Patients with schizophrenia have visual processing impairments. The main findings from the literature indicate that these deficits may be related to differences in paradigms, medications, and illness duration. This study is part of a large-scale study investigating visual sensitivity in schizophrenia. Here we aimed to investigate the combined effects of illness duration and antipsychotic use on contrast sensitivity function.
Data were collected from 50 healthy controls and 50 outpatients with schizophrenia (classified according to illness duration and medication type) aged 20-45 years old. The contrast sensitivity function was measured for spatial frequencies ranging from 0.2 to 20 cycles per degree using linear sine-wave gratings.
Patients with an illness duration > 5 years had more pronounced deficits. Differences in the combined effects of illness duration and antipsychotic use were marked in patients on typical antipsychotics who had been ill > 10 years. No significant differences were found between typical and atypical antipsychotics in patients with an illness duration < 5 years.
Visual impairment was related to both long illness duration and medication type. These results should be tested in further studies to investigate pharmacological mechanisms.
精神分裂症患者存在视觉处理障碍。文献中的主要发现表明,这些缺陷可能与范式、药物和疾病持续时间的差异有关。本研究是一项大规模研究的一部分,旨在调查精神分裂症患者的视觉敏感性。在这里,我们旨在研究疾病持续时间和抗精神病药物使用对对比敏感度功能的综合影响。
从年龄在 20-45 岁的 50 名健康对照者和 50 名精神分裂症门诊患者(根据疾病持续时间和药物类型分类)中收集数据。使用线性正弦光栅测量空间频率从 0.2 到 20 个周期/度的对比敏感度功能。
患病时间>5 年的患者有更明显的缺陷。在患病时间>10 年且使用典型抗精神病药物的患者中,疾病持续时间和抗精神病药物使用的综合效应差异明显。在患病时间<5 年的患者中,典型和非典型抗精神病药物之间没有发现显著差异。
视觉障碍与疾病持续时间和药物类型均有关。这些结果应在进一步的研究中进行测试,以研究药物机制。